Elanco Animal Health (ELAN)
NYSE: ELAN
· Real-Time Price · USD
20.64
0.18 (0.86%)
At close: Oct 03, 2025, 3:59 PM
20.68
0.19%
After-hours: Oct 03, 2025, 05:52 PM EDT
Elanco Animal Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.24B | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B | 1.03B | 1.07B | 1.06B | 1.26B | 988M | 1.03B | 1.18B | 1.23B | 1.11B | 1.13B | 1.28B | 1.24B |
Cost of Revenue | 664M | 637M | 631M | 625M | 626M | 648M | 654M | 627M | 570M | 628M | 578M | 600M | 617M | 646M | 651M | 643M | 680M | 716M |
Gross Profit | 577M | 556M | 389M | 405M | 558M | 557M | 381M | 441M | 487M | 629M | 410M | 426M | 558M | 580M | 462M | 488M | 599M | 526M |
Operating Income | 85M | 121M | 8M | -5M | 115M | 133M | 10M | 42M | 53M | 221M | 27M | 50M | 133M | 176M | 43M | 52M | 120M | 89M |
Interest Income | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 25M | 60M | -51M | 559M | -32M | 12M | -127M | -1.1B | -79M | 108M | -88M | -44M | -14M | 75M | -119M | -130M | -236M | -80M |
Net Income | 11M | 67M | -8M | 364M | -50M | 32M | -141M | -1.1B | -97M | 103M | -54M | -65M | -10M | 51M | -104M | -104M | -210M | -61M |
Selling & General & Admin | 400M | 341M | 300M | 323M | 354M | 337M | 292M | 313M | 353M | 327M | 303M | 298M | 343M | 323M | 327M | 342M | 385M | 348M |
Research & Development | 92M | 94M | 81M | 87M | 89M | 87M | 79M | 86M | 81M | 81M | 80M | 78M | 82M | 81M | 92M | 94M | 94M | 89M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 492M | 435M | 381M | 410M | 443M | 424M | 371M | 399M | 434M | 408M | 383M | 376M | 425M | 404M | 419M | 436M | 479M | 437M |
Interest Expense | 70M | 53M | 62M | 85M | 65M | 66M | 67M | 72M | 103M | 68M | 65M | 60M | 68M | 55M | 83M | 60M | 67M | 179M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.16B | 1.07B | 1.01B | 1.03B | 1.07B | 1.07B | 1.02B | 1.03B | 1B | 1.04B | 961M | 976M | 1.04B | 1.05B | 1.07B | 1.08B | 1.16B | 1.15B |
Income Tax Expense | 14M | -7M | -43M | 195M | 18M | -20M | 14M | -1M | 18M | 5M | -34M | 21M | -4M | 24M | -15M | -26M | -26M | -19M |
Shares Outstanding (Basic) | 496.6M | 495.1M | 494.4M | 494.3M | 494.2M | 493.2M | 492.8M | 492.7M | 492.6M | 491.1M | 488.5M | 488.4M | 488.4M | 488M | 487.4M | 487.3M | 487.3M | 486.7M |
Shares Outstanding (Diluted) | 500.1M | 499.1M | 494.4M | 497.7M | 494.2M | 496M | 492.8M | 492.7M | 492.6M | 492.8M | 488.5M | 488.4M | 488.4M | 492.2M | 487.4M | 487.3M | 487.3M | 486.7M |
EPS (Basic) | 0.02 | 0.14 | -0.02 | 0.74 | -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.13 | -0.02 | 0.10 | -0.2 | -0.21 | -0.43 | -0.13 |
EPS (Diluted) | 0.02 | 0.13 | -0.02 | 0.73 | -0.1 | 0.06 | -0.29 | -2.22 | -0.2 | 0.21 | -0.11 | -0.13 | -0.02 | 0.10 | -0.2 | -0.21 | -0.43 | -0.13 |
EBITDA | 264M | 274M | 175M | 814M | 195M | 244M | 111M | -852M | 201M | 349M | 146M | 183M | 225M | 306M | 138M | 100M | 1M | 301M |
EBIT | 95M | 113M | 11M | 644M | 33M | 78M | -60M | -1.02B | 24M | 176M | -23M | 16M | 54M | 130M | -36M | -70M | -169M | 99M |
Depreciation & Amortization | 169M | 161M | 164M | 170M | 162M | 166M | 171M | 173M | 177M | 173M | 169M | 167M | 171M | 176M | 174M | 170M | 170M | 202M |